A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors
Article in Cancer Medicine (March 2024)
The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.
Article in Cancer Medicine (March 2024)
Article in Molecules (January 2024)
Article in Chinese Journal of Hepatobiliary Surgery (December 2023)